In a spatial transcriptomics study of HER2-positive breast cancer [46], the researchers correlated pathologists with RNA expression-based clusters and found a high degree of consistency, and likewise found that data-driven expression-based clustering captured signals that were missed by visual inspection. The gene discussed is ERBB2; the disease is breast carcinoma.